Imatinib mesylate--a new oral targeted therapy

The New England Journal of Medicine
David G Savage, Karen H Antman

Abstract

No abstract listed.

References

Dec 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·G Q DaleyD Baltimore
Mar 24, 1994·The New England Journal of Medicine·UNKNOWN Italian Cooperative Study Group on Chronic Myeloid LeukemiaMauro Fiacchini
May 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R SzydloM M Horowitz
Jun 1, 1997·Baillière's Clinical Haematology·R A Clift, C Anasetti
Jan 13, 1998·Biochimica Et Biophysica Acta·A B RaitanoC L Sawyers
Jan 13, 1998·Biochimica Et Biophysica Acta·K S Kolibaba, B J Druker
Apr 2, 1998·The New England Journal of Medicine·J A HansenC Anasetti
Jan 15, 1999·The American Journal of Surgical Pathology·T S EmoryT J O'Leary
Jan 29, 1999·Journal of the National Cancer Institute·P le CoutreC Gambacorti-Passerini
Apr 29, 1999·The New England Journal of Medicine·C L Sawyers
Jul 15, 1999·The New England Journal of Medicine·S FaderlH M Kantarjian
Jan 5, 2000·The Journal of Clinical Investigation·B J Druker, N B Lydon
Jun 22, 2000·International Journal of Cancer. Journal International Du Cancer·A M TonaryB C Vanderhyden

❮ Previous
Next ❯

Citations

Oct 4, 2002·Hematological Oncology
Dec 20, 2005·Cancer Immunology, Immunotherapy : CII·Niels Schaft, Jan Dörrie
Apr 10, 2008·Cancer Chemotherapy and Pharmacology·Divya Menon-AndersenJeffrey S Barrett
Mar 19, 2013·Cancer Chemotherapy and Pharmacology·Shreyaskumar Patel
Oct 22, 2005·Pediatric Surgery International·Yutaka HayashiTakeshi Miyano
Jul 8, 2010·Journal of Bone and Mineral Metabolism·Kyu-Hyun YangSuk-Jin Kim
Feb 17, 2005·Digestive Diseases and Sciences·Ihab I El HajjNagi S El Saghir
Dec 4, 2010·Investigational New Drugs·Sridurga MithraprabhuAndrew Spencer
Sep 29, 2011·Inflammopharmacology·Dina S El-AgamyShehta A Said
Jun 12, 2008·Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract·Mehrdad NikfarjamKevin F Staveley-O'Carroll
Feb 19, 2005·Current Treatment Options in Oncology·Johnny Hyde, D Scott McMeekin
Apr 22, 2009·Current Treatment Options in Oncology·Jimmy Ruiz, Glenn J Lesser
Sep 1, 2006·Current Hematologic Malignancy Reports·Jeffrey A Zonder, Charles A Schiffer
Oct 2, 2002·Current Oncology Reports·Janice N CormierPeter W T Pisters
Jan 3, 2012·Head and Neck Pathology·Chia-Cheng LiSook-Bin Woo
Dec 12, 2003·European Urology·H G van der Poel
Apr 28, 2004·Leukemia Research·Pellegrino MustoAngelo Michele Carella
Jan 17, 2004·The Annals of Thoracic Surgery·Christian CasaliUliano Morandi
Dec 31, 2003·The Journal of Surgical Research·Robert Saeid FarivarEdward E Whang
Oct 8, 2003·Gynecologic Oncology·R Scott RushingSubodh M Lele
Sep 6, 2003·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J VerweijO S Nielsen
Jul 20, 2002·Current Opinion in Pharmacology·Doriano FabbroAlex Matter
Mar 16, 2004·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Michael Camilleri
Jun 12, 2003·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Robert A PariseMerrill J Egorin
Dec 22, 2012·Journal of Proteome Research·Lien-Chin ChenYu-Ju Chen
Jul 24, 2007·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Lisandro F Lopes, Carlos E Bacchi
May 28, 2004·Nature·John Bell
Oct 22, 2013·Nature Biotechnology·Christian S Hinrichs, Nicholas P Restifo
Aug 25, 2006·Nature Reviews. Cancer·Kohzoh Imai, Akinori Takaoka
Sep 7, 2013·Nature Reviews. Drug Discovery·Jane FridlyandHoward I Scher
Oct 3, 2002·British Journal of Haematology·Anne S TsaoMoshe Talpaz
Jul 5, 2002·The New England Journal of Medicine·Laszlo G BorosMarta Cascante
Oct 10, 2003·The New England Journal of Medicine·John M Goldman, Junia V Melo

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Lancet
A T van OosteromEuropean Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group
Best Practice & Research. Clinical Haematology
Andreas Hochhaus
© 2022 Meta ULC. All rights reserved